Studies in the Vilsmeier-Haack reaction, part VII: Synthesis and reaction of 3-methyl-1-phenyl-4-acetyl hydrazono 2-pyrazoline-5-one(-5-thione)
- 159 Downloads
- 15 Citations
Summary
The keto (thio) tautomers1–4 of the hydrazono pyrazolone, thiopyrazolone derivatives underwent simultaneous diformylation, chlorination (desulphurization) and ring closure under Vilsmeier reaction conditions giving the pyrazolo[3,4-c]pyrazole aminoacroleins (5,6). Treatment of5 and/or6 with proper reagents afforded the corresponding pyrazolo[3,4-c]pyrazoles with different heterocyclic systems at the 3-position.
The structures of these compounds were confirmed by elemental analysis, IR and1H-NMR spectroscopy. All synthesized compounds have been screened in vitro for their antibacterial activities against a number of Gram-positive and Gram-negative bacteria.
Keywords
Hydrazono-5-chloro pyrazole Pyrazolo[3,4-c]pyrazole Isoxazolylpyrazolo[3,4-c]-pyrazole Pyrazolylpyrazolo[3,4-c]pyrazole Physiological activityUntersuchungen zur Vilsmeier-Haack Reaktion, 7. Mitt.: Synthese und Reaktionen von 3-Methyl-1-phenyl-4-acetylhydrazono-2-pyrazolin-5-on(-5-thion)
Zusammenfassung
Die Keto-(Thio)-Tautomeren1–4 der Hydrazonopyrazolon-/Thiopyrazolon-Derivate gingen unter Vilsmeier-Bedingungen zugleich Diformylierung, Chlorierung (Entschwefelung) und Ringschluß zu Pyrazolo[3,4-c]pyrazol-aminoacroleinen5 und6 ein. Aus5 und/oder6 konnten die entsprechenden Pyrazolo[3,4-c]pyrazole mit verschiedenen heterocyclischen Systemen in 3-Position erhalten werden. Die Strukturen der Verbindungen wurden mittels Elementaranalyse, IR und1H-NMR überprüft. Alle synthetisierten Verbindungen wurden in vitro bezüglich ihrer antibakteriellen Aktivität gegenüber einer Anzahl Gram-positiver und Gram-negativer Bakterien untersucht.
Preview
Unable to display preview. Download preview PDF.
References
- [1]Nanda B., Padmanbbn S., Tripathy B., Mittra A. S. (1975) J. Indian Chem. Soc.52: 533Google Scholar
- [2]Nayak A., Das S., Misra C. R., Mittra S. A. (1977) J. Indian Chem. Soc.54: 485Google Scholar
- [3]Mohanty S. K., Sridhar R., Padmanavan S. Y., Rao S., Mittra A. S. (1977) Indian J. Chem.15B: 1146Google Scholar
- [4]Archer A. (1968) U. S. Patent 8,365,453, 23 Jan.; (1968) C. A.69: 27458Google Scholar
- [5]Surrey A. R., Meyer J. R. (1961) J. Med. Pharm. Chem.3: 409Google Scholar
- [6]Messarani E., Mardi D., Rossi S., Degan L. (1971) J. Med. Chem.14: 635Google Scholar
- [7]Awad I. M. A., Hassan Kh. M. (1988) Coll. Czech. Commun.54: 706Google Scholar
- [8]Awad I. M. A., Hassan Kh. M. (1989) Phosphorus, Sulfur, and Silicon44: 135Google Scholar
- [9]Awad I. M. A., Hassan Kh. M. (1989) Phosphorus, Sulfur and Silicon44 Google Scholar
- [10]Awad I. M. A., Hassan Kh. M. (1989) Phosphorus, Sulfur and Silicon45: 155Google Scholar
- [11]Awad I. M. A., Hassan K. M. (in press) J. Chinese Chem. Soc.Google Scholar
- [12]Solisman E. A., Abdalla M. M., Mohammed M. M., Elgindy A. M. (1978) Indian J. Chem.16B: 505Google Scholar
- [13]Cremer A. (1980) Antibiotic Sensitivity and Assay Tests in Collins, 4th Ed. Butterworths, London, p. 521Google Scholar
- [14]British Pharmacopeia (1953) Pharmaceutical Press, London, p. 796Google Scholar
- [15]Chaturvedi K. K., Jain N. K., Jain P., Kaushal R. (1978) Indian Drugs15: 57Google Scholar